Companion Animal Specialty Drugs Market
Market Insights on Companion Animal Specialty Drugs covering sales outlook, demand forecast & up-to-date key trends
Companion Animal Specialty Drugs Market By Product (Antibiotics, Anti-Inflammatory Drugs, Parasiticides, Heartworm, Behavioral Products), Distribution Channel (Modern Trade, Online Distribution, Neighborhood Stores, Other Retail Format) & Region - Forecast 2021 - 2031
Companion Animal Specialty Drugs Market Snapshot
As per the Future Market Insights’ (FMI) study, companion animal specialty drugs sales will increase at 4.21% CAGR between 2021 and 2031. The overall market value is projected to reach US$ 36,104.66 Mn in 2021.
With growing popularity of veterinary science as a profession and increasing adoption of companion animals across the U.S., India, the U.K., and Germany, demand for companion animal specialty drugs will rise.
As per FMI’s analysis, Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH are the top players in the market. These companies are expected to account for over 85% of market share in 2021.
Let us know your requirement to get
100% FREE customization
Key Points Covered in Companion Animal Specialty Drugs Market Study
- Market estimates and forecast 2021-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Companion Animal Specialty Drugs Market and How to Navigate
- Recommendation on Key Winning Strategies
How is Future Projection of Companion Animal Specialty Drugs Market Outpacing Historical Sales?
Demand for companion animal specialty drugs increased at a steady pace in the last five years. As per FMI, the market exhibited growth at 5.43% CAGR between 2016 and 2020. Increasing urbanization and adoption of companion animals across the globe will facilitate growth in the market through the assessment period.
The market is slated to gain from the advent of novel technologies and increased research & development activities aimed at developing advanced vaccines, nutritional products, and anti-obesity drugs have spurred the demand.
Development of recombinant DNA vaccines for dogs is expected to drive the demand for companion animal specialty drugs over the coming years. Due to the rise in vector-borne diseases, adoption of parasiticides has increased, which has improved the market demand.
Increasing prevalence of obesity among pet dogs, especially across the U.K. and Germany have increased the demand for anti-obesity drugs. This has encouraged market players to introduce novel drugs to curb spread of diseases and obesity rate among companion animals.
Spurred by this, the market registered steady year-on-year growth at 5.42% CAGR during 2020-21. Increasing adoption of dogs across the developed nations, including the U.S., Germany and the U.K. will increase the adoption of nutritional products and behavioral products among the pet owners.
Rising Geriatric Population Driving Companion Animal Specialty Drugs Market
Adoption of pets among elderly population has been driving demand for companion animal specialty drugs services. Baby boomers have been increasingly adopting cats and dogs as pets, especially across the U.S. and the U.K.
A clean and hygienic atmosphere at home is essential and preferred by older people. This has led to increased adoption of prophylactic medications for pets and the trend is expected to continue in the upcoming years.
There were more than 3.7 Mn pet owners among the baby boomer generation in the U.S. in 2019, as per American Society for the Prevention of Cruelty to Animals. Pet adoption has been increasing mostly for dogs while feline pet ownership rates have remained stagnant globally over the past five years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystApproval of New Drugs Bolstering Growth
Development and approval of new drugs for the treatment of animal diseases is expected to increase the growth of overall market.
For example - In May 2016, the company announced the approval from the European Medicines Agency (EMA) for Bravecto Spot-On Solution for cats and dogs, and in July 2016, the company received approval in the U.S. to market the product under the trade name Bravecto Topical.
Also, in June 2020, Merck announced the investment of US$ 20 Mn for the facility expansion and improvement in its manufacturing site established in the U.S. in De Soto, Kansas. The site produces vaccines and the investment was for the improvement of its production capabilities to cater the demand for compounded vaccines.
Country-wise Insights
How is the Companion Animal Specialty Drugs Market Expanding in the U.S.?
The companion animal specialty drugs market is poised to accrue significant gains across the U.S. Rising adoption of pet across the country have improved the sales of companion animal specialty drugs.
According to the survey of American Society for the Prevention of Cruelty to Animals, nearly 6.5 million companion animals enter the U.S. animal shelters every year. Among these, 3.3 million are dogs and 3.2 million are cats. Approximately, 3.2 million shelter animals are adopted every year.
It is estimated that around 44% of households in the U.S. have a dog and nearly 33% have a cat. With growing adoption of companion animals in the U.S., pet owners are increasing their awareness about the maintenance of their pet. Now, internet being the primary source and with rising penetration of social media, millennials and baby boomers are taking extra-care for their pet wellbeing.
This includes proper vaccination for their pet, which is directly impacting the companion animal specialty drugs market positively. Apart from this, rising cases of vector borne diseases among the companion animals will fuel demand in the U.S. market.
How will Demand for Companion Animal Specialty Drugs Fare in the U.K.?
The U.K. is anticipated to be the most lucrative market across Europe for companion animal specialty drugs. Growth registered in the U.K. can be attributed to the growing adoption of companion animals across the country.
Obesity in pets is another major factor driving the companion animal specialty drugs market. A study by Royal Veterinary College has revealed that 1 in 14 dogs in the U.K. are recorded by their vets as overweight.
Pet Food Manufacture Association stated in its White Paper-2019 survey that, 74% of veterinary professionals believe that prevalence of obesity has increased over the past 5 years. To reduce the statistics, many private and public organizations are encouraging the use of anti-obesity drugs and nutritional products, propelling the demand for companion animal specialty drugs market across the U.K.
How is Germany’s Companion Animal Specialty Drugs Market Expected to Perform?
With initiatives undertaken to lower the obesity rate among companion animals and rapid adoption of nutritional and anti-obesity drugs, the Germany’s companion animal specialty drugs market is expected to witness significant growth during the assessment period.
Alongside this, adoption of pets across Germany have increased the growth prospects for the market players. Unprecedented outbreak of coronavirus compelled people around the world to spend more time indoors, resulting in increased adoption of dogs.
Global shutdown caused a spike in demand for companion animals, especially puppies in Germany. According to the German Canine Association (VDH), demand for dogs across Germany increased by 20% in FQ-20.
With rising adoption, demand for nutritional products, anti-inflammatory medicines, and other drugs for pets burgeoned.
What are the Key Factors Enabling Growth in India?
India is expected to dominate the South Asia’s companion animal specialty drugs market during the forecast period. Demand for vaccines, nutritional products, behavioral drugs, and specialty drugs will increase due to the rising adoption of companion animals.
Growing urbanization, technological advancements, and awareness regarding animal cruelty have significantly improved the adoption of companion animals across India. Penetration of social media and campaigns implemented to increase the awareness about the cruelty against animals and pet adoption have impacted the market positively.
As per National Geographic statistics, India is home to around 35 million street dogs and the number is likely to increase by 2030. Recently, due to Covid-19 adoption of dogs have significantly increased in India, says Humanities and Social Sciences Communications. This has in turn resulted in higher focus on the treatment of companion animals for various diseases, which will bode well for the market in India.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Which is the Top-selling Companion Animal Specialty Drug?
FMI estimates, parasiticides segment is expected to account for over 32% of revenue share in the global companion animal specialty drugs market. Increasing adoption for treatment of various animal diseases have prompted the growth of this segment.
Veterinary parasiticides or antiparasitics are the products that treat vector-borne diseases and kill parasites that infect pets, livestock, and other animals. Rising prevalence of vector-borne diseases among pets, especially dogs, have increased the adoption of parasiticides within veterinary clinics and hospitals.
What is the Scope of Sales through Veterinary Clinics?
Demand for companion animal specialty drugs for the veterinary clinics distribution channel is anticipated to be relatively strong, owing to the increasing pet adoption and rising awareness among the people regarding animal diseases.
As per Future Market Insights, the veterinary clinics segment is anticipated to contribute over 52% of value share in global companion animal specialty drugs market during the forecast period.
Competitive Landscape
Future Market Insights forecasts, increasing strategic acquisition and collaboration activities among the companies has led to intense consolidation. Key players are also focusing on research and development activities to develop more effective drugs for the treatment of cats and dogs.
For instance, Aeronics Inc., a Pittsburgh-based startup that develops innovative oxygen technologies for veterinary use announced the collaboration with MWI Animal Health, a leading distributor of animal health products to expedite veterinarians access to portable oxygen.
Also, in January 2021, Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada, a division of Merck & Co. Inc., announced the collaboration with the Street Dog Coalition to offer medications, vaccines, treatment for pets of those experiencing homelessness.
In June 2021, ALR Technologies SG Pvt. Ltd., the diabetes management company announced the establishment of its new business division which will be the world’s first and only CGM for diabetic companion animals, known as, ‘ALRT Animal Health Division’.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
|
Key Segments Covered |
Distribution Channel, Product, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Companion Animal Specialty Drugs Market by Category
By Product:
- Antibiotics
- Anti-Inflammatory Drugs
- Parasiticides
- Heartworm
- Behavioral Products
- Nutritional Products
- Anti-Obesity Drugs
- Skin Care Products
- Vaccines
By Distribution Channel:
- Modern Trade
- Online Distribution
- Neighborhood Stores
- Other Retail Format
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Frequently Asked Questions
The companion animal specialty drugs market is expected to exceed US$36,104.66 Mn in 2021
The companion animal specialty drugs market projected steady growth, registering a CAGR at 5.43% between 2016 and 2020.
Growing demand for compounded medications and increasing adoption of anti-obesity drugs to reduce the growing obesity rate among pets will drive the sales.
Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH, are the top players FMI identifies as key players.
North America’s companion animal specialty drugs market demand is set to rise at over 3.38% CAGR during the forecast period of 2021 and 2031.
The top 10 players in the companion animal specialty drugs market will collectively account for over 85% of global market share in the year 2021.
Demand for companion animal specialty drugs across Europe will exhibit steady expansion at 5.28% during the forecast period of 2021 and 2031.
Top countries in terms of companion animal specialty drugs distribution are China, the U.K., the U.S., India and Germany.
In 2021, Japan accounted for 6.4% market share while South Korea contributed less than 1% market share.
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Companion Animal Drugs Market Analysis Scenario
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunity
4.4. Global Trends
4.5. PEST Analysis - U.S.
4.6. PEST Analysis - Europe
4.7. Portor's Five Analysis
4.8. Trilateral regulatory harmonization between U.S., EU and Japan on registration of veterinary products
5. Global Companion Animal Drugs Market Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value Forecast By Product Type, 2021–2031
5.4.1. Antibiotics
5.4.2. Anti-inflammatory Drugs
5.4.3. Parasiticides
5.4.4. Heartworm
5.4.5. Behavioral Products
5.4.6. Nutritional Products
5.4.7. Anti-Obesity Drugs
5.4.8. Skin Care Products
5.4.9. Vaccines
5.5. Market Attractiveness By Product Type
6. Global Companion Animal Drugs Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel
6.3. Y-o-Y Growth Projections By Distribution Channel
6.4. Market Value Forecast By Distribution Channel, 2021–2031
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
6.4.3. Pharmacies and Drug Stores
6.5. Market Attractiveness By Distribution Channel
7. Global Companion Animal Drugs Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. APEJ
7.3.6. Japan
7.3.7. MEA
7.4. Market Attractiveness By Region
8. North America Companion Animal Drugs Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type, 2021–2031
8.2.1. Antibiotics
8.2.2. Anti-inflammatory Drugs
8.2.3. Parasiticides
8.2.4. Heartworm
8.2.5. Behavioral Products
8.2.6. Nutritional Products
8.2.7. Anti-Obesity Drugs
8.2.8. Skin Care Products
8.2.9. Vaccines
8.3. Market Value Forecast By Distribution Channel, 2021–2031
8.3.1. Veterinary Hospitals
8.3.2. Veterinary Clinics
8.3.3. Pharmacies and Drug Stores
8.4. Market Value Forecast By Country, 2021–2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By Distribution Channel
8.5.3. By Country
8.6. Regional Trends
8.7. Drivers and Restraints: Impact Analysis
9. Latin America Companion Animal Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type, 2021–2031
9.2.1. Antibiotics
9.2.2. Anti-inflammatory Drugs
9.2.3. Parasiticides
9.2.4. Heartworm
9.2.5. Behavioral Products
9.2.6. Nutritional Products
9.2.7. Anti-Obesity Drugs
9.2.8. Skin Care Products
9.2.9. Vaccines
9.3. Market Value Forecast By Distribution Channel, 2021–2031
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Pharmacies and Drug Stores
9.4. Market Value Forecast By Country, 2021–2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of Latin America
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country
9.6. Regional Trends
9.7. Drivers and Restraints: Impact Analysis
10. Western Europe Companion Animal Drugs Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2.Market Value Forecast By Product Type, 2021–2031
10.2.1. Antibiotics
10.2.2. Anti-inflammatory Drugs
10.2.3. Parasiticides
10.2.4. Heartworm
10.2.5. Behavioral Products
10.2.6. Nutritional Products
10.2.7. Anti-Obesity Drugs
10.2.8. Skin Care Products
10.2.9. Vaccines
10.3.Market Value Forecast By Distribution Channel, 2021–2031
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Pharmacies and Drug Stores
10.4.Market Value Forecast By Country, 2021–2031
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Nordics
10.4.7. Benelux
10.4.8. Rest of Western Europe
10.5.Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country
10.6. Regional Trends
10.7. Drivers and Restraints: Impact Analysis
11. Eastern Europe Companion Animal Drugs Market Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2.Market Value Forecast By Product Type, 2021–2031
11.2.1. Antibiotics
11.2.2. Anti-inflammatory Drugs
11.2.3. Parasiticides
11.2.4. Heartworm
11.2.5. Behavioral Products
11.2.6. Nutritional Products
11.2.7. Anti-Obesity Drugs
11.2.8. Skin Care Products
11.2.9. Vaccines
11.3.Market Value Forecast By Distribution Channel, 2021–2031
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.3.3. Pharmacies and Drug Stores
11.4.Market Value Forecast By Country, 2021–2031
11.4.1. Russia
11.4.2. Poland
11.4.3. Rest of Eastern Europe
11.5.Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Distribution Channel
11.5.3. By Country
11.6. Regional Trends
11.7. Drivers and Restraints: Impact Analysis
12. APEJ Companion Animal Drugs Market Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2.Market Value Forecast By Product Type, 2021–2031
12.2.1. Antibiotics
12.2.2. Anti-inflammatory Drugs
12.2.3. Parasiticides
12.2.4. Heartworm
12.2.5. Behavioral Products
12.2.6. Nutritional Products
12.2.7. Anti-Obesity Drugs
12.2.8. Skin Care Products
12.2.9. Vaccines
12.3.Market Value Forecast By Distribution Channel, 2021–2031
12.3.1. Veterinary Hospitals
12.3.2. Veterinary Clinics
12.3.3. Pharmacies and Drug Stores
12.4.Market Value Forecast By Country, 2021–2031
12.4.1. China
12.4.2. India
12.4.3. Australia & New Zealand
12.4.4. ASEAN
12.4.5. Rest of APEJ
12.5.Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Distribution Channel
12.5.3. By Country
12.6. Regional Trends
12.7. Drivers and Restraints: Impact Analysis
13. Japan Companion Animal Drugs Market Analysis and Forecast
13.1.Introduction
13.1.1. Absolute $ Opportunity (US$ Mn), 2021–2031
13.2.Market Value Forecast By Product Type, 2021–2031
13.2.1. Antibiotics
13.2.2. Anti-inflammatory Drugs
13.2.3. Parasiticides
13.2.4. Heartworm
13.2.5. Behavioral Products
13.2.6. Nutritional Products
13.2.7. Anti-Obesity Drugs
13.2.8. Skin Care Products
13.2.9. Vaccines
13.3.Market Value Forecast By Distribution Channel, 2021–2031
13.3.1. Veterinary Hospitals
13.3.2. Veterinary Clinics
13.3.3. Pharmacies and Drug Stores
13.4.Market Attractiveness Analysis
13.4.1. By Product Type
13.4.2. By Distribution Channel
13.5. Regional Trends
13.6. Drivers and Restraints: Impact Analysis
14. MEA Companion Animal Drugs Market Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2.Market Value Forecast By Product Type, 2021–2031
14.2.1. Antibiotics
14.2.2. Anti-inflammatory Drugs
14.2.3. Parasiticides
14.2.4. Heartworm
14.2.5. Behavioral Products
14.2.6. Nutritional Products
14.2.7. Anti-Obesity Drugs
14.2.8. Skin Care Products
14.2.9. Vaccines
14.3.Market Value Forecast By Distribution Channel, 2021–2031
14.3.1. Veterinary Hospitals
14.3.2. Veterinary Clinics
14.3.3. Pharmacies and Drug Stores
14.4.Market Value Forecast By Country, 2021–2031
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5.Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By Distribution Channel
14.5.3. By Country
14.6. Regional Trends
14.7. Drivers and Restraints: Impact Analysis
15. Competition Landscape
15.1. Competition Dashboard
15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments and SWOT Analysis)
15.2.1. Zoetis, Inc.
15.2.2. Merck and Co., Inc.
15.2.3. Bayer AG
15.2.4. Elanco
15.2.5. Boehringer Ingelheim Animal Health
15.2.6. Ceva Santé Animale
16. Assumptions and Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product Type, 2021 - 2031
Table 02: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 03: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Region, 2021 - 2031
Table 04: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 05: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 06: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 07: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 08: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 09: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 10: Western Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 11: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 12: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 13: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 14: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 15: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 16: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 17: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 18: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 19 : Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast, 2021 - 2031
Table 20: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 21: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Table 22: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031
Table 23: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031
Table 24: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Companion Animal Drugs Market Size (US$ Mn) By Product Type, 2021 & 2031
Figure 02: Global Companion Animal Drugs Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 03: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Product Type, 2021 - 2031
Figure 04: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Antibiotics Segment, 2021 - 2031
Figure 05: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-inflammatory Drugs Segment, 2021 - 2031
Figure 06: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Parasiticides Segment, 2021 - 2031
Figure 07: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Heartworm Segment, 2021 - 2031
Figure 08: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Behavioral Products Segment, 2021 - 2031
Figure 09: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) Nutritional Products Segment, 2021 - 2031
Figure 10: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-Obesity Drugs Segment, 2021 - 2031
Figure 11: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Skin Care Products Segment, 2021 - 2031
Figure 12: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Vaccines Segment, 2021 - 2031
Figure 13: Global Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 14 : Global Companion Animal Drugs Market Size (US$ Mn) By Distribution Channel, 2021 & 2031
Figure 15: Global Companion Animal Drugs Market Share by Distribution Channel, 2021 - 2031
Figure 16: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2021 - 2031
Figure 17: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals Segment, 2021 - 2031
Figure 18: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2021 - 2031
Figure 19: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Pharmacies and Drug Stores Segment, 2021 - 2031
Figure 20: Global Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 21: Global Companion Animal Drugs Market Size (US$ Mn) By Region, 2021 & 2031
Figure 22: Global Companion Animal Drugs Market Share Analysis (%) By Region, 2021 & 2031
Figure 23: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Region, 2021 - 2031
Figure 24: North America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 25: Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 26: Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 27: Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 28: APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 29: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 30: MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 31: Global Companion Animal Drugs Market Attractiveness Analysis By Region, 2021 - 2031
Figure 32: North America Companion Animal Drugs Market Share Analysis (%) By Country, 2017 - 2027
Figure 33: North America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 34: The U.S. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 35: Canada Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 36: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 37: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 38: Global Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Figure 39: Latin America Companion Animal Drugs Market Share Analysis (%) By Country, 2021 - 2031
Figure 40: Latin America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 41: Brazil Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 42: Mexico Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 43: Argentina Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 44: Rest of Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 45: Latin America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 46: Latin America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 47: Latin America Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Figure 48: Western Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031
Figure 49: Western Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 50: U.K. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 51: Germany Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 52: France Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 53: Italy Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 54: Spain Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 55: Nordic Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 56: Benelux Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 57: Rest of Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 58: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 59: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 60: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Figure 61: Eastern Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 - 2031
Figure 62: Eastern Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 63: Russia Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 64: Poland Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 65: Rest of Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 66: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 67: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 68: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Figure 69: APEJ Companion Animal Drugs Market Share Analysis (%) By Country, 2017 & 2027
Figure 70: APEJ Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 71: China Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 72: India Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 73: A&NZ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 74: ASEAN Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 75: Rest of APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 76: APEJ Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 77: APEJ Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 78: APEJ Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Figure 79: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 80: Japan Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 81: Japan Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 82: MEA Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031
Figure 83: MEA Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031
Figure 84: GCC countries Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 85: South Africa Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 86: Rest of MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 87: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031
Figure 88: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031
Figure 89: MEA Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
